Role of acidic sphingomyelinase in Fas/CD95-mediated cell death

被引:112
作者
Lin, T
Genestier, L
Pinkoski, MJ
Castro, A
Nicholas, S
Mogil, R
Paris, F
Fuks, Z
Schuchman, EH
Kolesnick, RN
Green, DR [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA
[2] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.275.12.8657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Engagement of the Fas receptor has been reported to induce ceramide generation via activation of acidic sphingomyelinase (aSMase). However, the role of aSMase in Fas-mediated cell, death is controversial. Using genetically engineered mice deficient in the aSMase gene (aSMase(-/-)), we found that thymocytes, concanavalin A-activated T cells, and lipopolysaccharide-activated B cells derived from both aSMase(-/-) and aSMase(+/+) mice were equally sensitive to Fas-mediated cell death, triggered by either anti-Fas antibody or Fas ligand in vitro. Similarly, activation-induced apoptosis of T lymphocytes was unaffected by the status of aSMase, and aSMase(-/-) mice failed to show immunological symptoms seen in animals with defects in Fas function, In vivo, intravenous injection of 3 mu g/25 g mouse body weight of anti-Fas Jo2 antibody into asMase(-/-) mice failed to affect hepatocyte apoptosis or mortality, whereas massive hepatocyte apoptosis and animal death occurred in wild type littermates, Animals heterozygous for aSMase deficiency were also significantly protected. Susceptibility of aSMase(-/-) mice to anti-Fas antibody was demonstrated with higher antibody doses (greater than or equal to 4 mu g/25 g mouse). These data indicate a role for aSMase in Fas-mediated cell death in some but not all tissues.
引用
收藏
页码:8657 / 8663
页数:7
相关论文
共 51 条
[31]   FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex [J].
Muzio, M ;
Chinnaiyan, AM ;
Kischkel, FC ;
ORourke, K ;
Shevchenko, A ;
Ni, J ;
Scaffidi, C ;
Bretz, JD ;
Zhang, M ;
Gentz, R ;
Mann, M ;
Krammer, PH ;
Peter, ME ;
Dixit, VM .
CELL, 1996, 85 (06) :817-827
[32]  
Nagata S, 1994, Semin Immunol, V6, P3, DOI 10.1006/smim.1994.1002
[33]   PROGRAMMED CELL-DEATH INDUCED BY CERAMIDE [J].
OBEID, LM ;
LINARDIC, CM ;
KAROLAK, LA ;
HANNUN, YA .
SCIENCE, 1993, 259 (5102) :1769-1771
[34]   SELECTIVE APOPTOSIS OF CD4(+)CD8(+) THYMOCYTES BY THE ANTI-FAS ANTIBODY [J].
OGASAWARA, J ;
SUDA, T ;
NAGATA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :485-491
[35]   LETHAL EFFECT OF THE ANTI-FAS ANTIBODY IN MICE [J].
OGASAWARA, J ;
WATANABEFUKUNAGA, R ;
ADACHI, M ;
MATSUZAWA, A ;
KASUGAI, T ;
KITAMURA, Y ;
ITOH, N ;
SUDA, T ;
NAGATA, S .
NATURE, 1993, 364 (6440) :806-809
[36]  
PENA LA, 2000, IN PRESS CANC RES
[37]   CD95 (FAS) DEPENDENT ELIMINATION OF SELF-REACTIVE B-CELLS UPON INTERACTION WITH CD4(+) T-CELLS [J].
RATHMELL, JC ;
COOKE, MP ;
HO, WY ;
GREIN, J ;
TOWNSEND, SE ;
DAVIS, MM ;
GOODNOW, CC .
NATURE, 1995, 376 (6536) :181-184
[38]   Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor [J].
Rathmell, JC ;
Townsend, SE ;
Xu, JCC ;
Flavell, RA ;
Goodnow, CC .
CELL, 1996, 87 (02) :319-329
[39]   A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection [J].
Rodriguez, I ;
Matsuura, K ;
Khatib, K ;
Reed, JC ;
Nagata, S ;
Vassalli, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1031-1036
[40]   Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis [J].
Santana, P ;
Pena, LA ;
HaimovitzFriedman, A ;
Martin, S ;
Green, D ;
McLoughlin, M ;
CordonCardo, C ;
Schuchman, EH ;
Fuks, Z ;
Kolesnick, R .
CELL, 1996, 86 (02) :189-199